Adam Feuerstein articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2014/08/27 04:22
2014/08/27 04:22
6d
Updated from 6:07 am EDT with additional Galena comment.Lake Oswego, Oreg. (TheStreet) -- Galena Biopharma(GALE) CEO Mark Ahn was fired by the board of directors at a special meeting held Monday,...
2014/08/27 04:22
2014/08/27 04:22
Latest videos
2014/08/26 14:22
2014/08/26 14:22
6d
BOSTON (TheStreet) -- If you're like me, a dad with school-age kids, September is a real page turner in the calendar. Everyone gets a fresh start on January 1, but Labor Day serves the same purpose....
2014/08/25 11:22
2014/08/25 11:22
7d
The all-cash deal values InterMune at $74 per share, or a 38% premium to Friday's closing stock price. Roche says the acquisition will be neutral to 2015 earnings and accretive in 2016. InterMune's...
2014/08/24 16:22
2014/08/24 16:22
8d
The all-cash deal values InterMune at $74 per share, or a 38% premium to Friday's closing stock price. Roche says the acquisition will be neutral to 2015 earnings and accretive in 2016. Here's the...
2014/08/22 13:22
2014/08/22 13:22
10d
Biotech Stock Mailbag: Threshold, Galena, CytRx BOSTON (TheStreet) -- A late summer Biotech Stock Mailbag. Sean L. writes: Big fan and follower of all things biotech. I came across the...
2014/08/21 11:22
2014/08/21 11:22
11d
Updated from 6:07 am EDT with additional Galena comment.Lake Oswego, Oreg. (TheStreet) -- Galena Biopharma(GALE) CEO Mark Ahn was fired by the board of directors at a special meeting held Monday,...
2014/08/20 10:22
2014/08/20 10:22
12d
CRANBURY, NJ (TheStreet) -- Amicus Therapeutics(FOLD) CEO John Crowley came close to permanently shelving his company's experimental Fabry disease therapy following disappointing results from a...
2014/08/15 12:22
2014/08/15 12:22
17d
BOSTON (TheStreet) -- Welcome back to the Biotech Stock Mailbag. Richard V. asks: Adam, I follow you on Twitter and saw you comment on Exact Sciences(EXAS) and the pricing of Cologuard. Can you...
2014/08/11 12:22
2014/08/11 12:22
21d
... impressed me with his ambition and his knowledge of drug development, which is why I am invested in the company," said another Retrophin shareholder who asked not be identified by name. "But...
2014/08/11 11:22
2014/08/11 11:22
21d
Sanofi (SNY), an established Big Pharma player in the global diabetes market, will market Afrezza worldwide in exchange for a $150 million upfront license fee paid to MannKind. The two companies will...
2014/08/07 00:17
2014/08/07 00:17
26d
If you purchased or acquired Galectin publicly traded securities during the Class Period, you may move the Court for appointment as lead plaintiff by no later than September 29, 2014. A lead plaintiff...
2014/08/01 12:22
2014/08/01 12:22
1m
BOSTON (TheStreet) -- A discussion of an experimental hepatitis B therapy kicks off this week's Biotech Stock Mailbag. Arrowhead is conducting a phase IIa study of ARC-520 in hepatitis B patients,...
2014/07/31 21:22
2014/07/31 21:22
m
NEW YORK (TheStreet) -- U.S. stock markets plummeted on volatile trading Thursday as mixed earnings reports, concerns about the health of the European economy and financial sector and the wait for...
2014/07/31 13:22
2014/07/31 13:22
m
You're not hallucinating. This longtime Amarin bear believes there's now a compelling argument for going long the stock or its options -- if only for a speculative trade. The idea of being long Amarin...
2014/08/27 04:22
2014/08/27 04:22
Latest from Twitter